# US 2013/0252909 A1 · Tannin inhibitors of hiv

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252909 A1
- Document ID: US20130252909A1
- Status: Published application
- Kind: A1
- Application number: 13/788,691
- Filed: 2013-03-07
- Published: 2013-09-26
- Earliest claimed: 2012-03-23
- Assignees: University of Iowa Research Foundation
- Applicants: University of Iowa Research Foundation
- Inventors: George A. Kraus; Wendy Maury
- Web page: https://patentgrep.com/patent/US20130252909A1

## CPC

- A61K 31/70: Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047)
- A61K 31/22: of acyclic acids, e.g. pravastatin
- A61K 31/365: Lactones
- A61K 31/366: having six-membered rings, e.g. delta-lactones
- C07D 321/12: Eight-membered rings
- C07H 3/02: Monosaccharides
- C07H 13/08: having the esterifying carboxyl radicals directly attached to carbocyclic rings
- C07H 15/04: attached to an oxygen atom of the saccharide radical
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The invention provides a method to prevent or treat HIV-infection with synthetic tannins, and pharmaceutical compositions comprising synthetic tannins.

## Claims

### Claim 1

A method for treating HIV infection comprising administering to a subject afflicted with HIV infection an effective anti-HIV amount of a compound of formula (I):
wherein R1, R2, and R3 are individually H, (C1-C4)alkyl or galloyl (G), p is 0 or 1, m is 0 or 1, and n is 0 or 1, with the proviso that when n is 0 there is a single bond between C2 and C4, and when p is 0, C1 is CH2.

### Claim 2 (depends on 1)

The method of claim 1 wherein n is 1, m is 1, and p is 1.

### Claim 3 (depends on 2)

The method of claim 2 wherein R1 is CH3.

### Claim 4 (depends on 3)

The method of claim 3 wherein R2 and R3 are G or H.

### Claim 5 (depends on 2)

The method of claim 2 wherein R1 is G or H.

### Claim 6 (depends on 5)

The method of claim 5 wherein R2 is H or G and R3 is H or G.

### Claim 7 (depends on 6)

The method of claim 6 wherein R2 and R3 are H.

### Claim 8 (depends on 7)

The method of claim 7 wherein R1 is H.

### Claim 9 (depends on 1)

The method of claim 1 wherein the moiety:

### Claim 10 (depends on 1)

The method of claim 1 wherein the moiety:

### Claim 11 (depends on 1)

The method of claim 1 wherein n is 0.

### Claim 12 (depends on 11)

The method of claim 11 wherein the moiety:

### Claim 13 (depends on 11)

The method of claim 11 wherein R1 or R2 is CH3.

### Claim 14 (depends on 11)

The method of claim 11 wherein R1 and/or R2 are G.

### Claim 15 (depends on 1)

The method of claim 1 wherein n is 1, m is 0 and p is 0.

### Claim 16 (depends on 15)

The method of claim 15 wherein the moiety:

### Claim 17 (depends on 16)

The method of claim 16 wherein R2 and/or R3 are G.

### Claim 18 (depends on 17)

The method of claim 17 wherein R2 or R3 are CH3.

### Claim 19

A method for treating HIV infection comprising administering to a subject afflicted with HIV an effective anti-HIV amount of a compound of formula (II):
wherein R1, R2 and R3 are individually H, (C1-C4)alkyl or galloyl (G), wherein at least one of R1, R2 or R3 is G.

### Claim 20 (depends on 19)

The method of claim 19 wherein R2 is G.

### Claim 21 (depends on 20)

The method of claim 20 wherein R1 and R3 are H.

### Claim 22

A method for treating HIV infection comprising administering to a subject afflicted with HIV infection an anti-HIV amount of a compound of formula (III):
wherein R1, R2 and R3 are individually H, (C1-C4)alkyl or galloyl (G), wherein at least one of R1, R2 or R3 is G.

### Claim 23 (depends on 22)

The method of claim 22 wherein R1 and/or R3 are G.

### Claim 24 (depends on 23)

The method of claim 23 wherein R2 is H.

### Claim 25

A compound of the formula:

### Claim 26

A compound of the formula:

### Claim 27

A compound of the formula:

### Claim 28

A compound of the formula:
wherein OH is α-OH, β-OH or a mixture thereof.

### Claim 29

A compound of the formula:
